Product support, training and education for professionals
Click2Print complements the high standard of care already provided by ocularists. By broadening your range of technology, you can focus on your core expertise of matching the best prosthetic to your patient aesthetically, quickly and comfortably.
Every person is unique and deserves the best possible prosthesis
Our product won’t always be suitable for your patient, so we support you by building your knowledge on whether a 3D printed ocular prosthesis is the right choice. To help you with their decision, training is mandatory to use Click2Print by an ocularist who has a minimum of five years ocularistry experience. This training will also cover how to obtain a perfectly fitted artificial eye. Training modules in digital ocularistry are available from your ocularist training body – please contact us if you are unsure who your ocularist training body is.
We anticipate that as machine and material technology improves, this in turn will advance ocular prosthetics to the next level. Continuing your education in this fast evolving technology market will enhance your fitting and patient experience, as well as confidently discuss the benefits of 3D printing.
To support you in making the best decision for your patients, we’ve collated the following papers and articles
- Papers
Automatic data-driven design and 3D printing of custom ocular prostheses
Reinhard, J., Urban, P., Bell, S. et al. Automatic data-driven design and 3D printing of custom ocular prostheses. Nat Commun 15, 1360 (2024).
- Articles
Applications of three-dimensional printing in ophthalmology
Tsui, J.K.S., Bell, S., Cruz, L. da, Dick, A.D. and Sagoo, M.S. (2022). Applications of three-dimensional printing in ophthalmology. Survey of Ophthalmology, [online] 67(4), pp.1287–1310.
Anterior segment optical coherence tomography for imaging the anophthalmic socket
Sagoo, M.S., Bell, S., Carpenter, D. et al. Anterior segment optical coherence tomography for imaging the anophthalmic socket. Eye 34, 1479–1481 (2020).